Partners and investors
Sanquinnovate is committed to partner with innovators in the fight against serious diseases in the field of hematology, immunology and oncology.
Sanquinnovate actively scouts and evaluates these ideas with the focus on their added value for patients, patentability, competitive advantage, and of course scientific excellence. Once ideas have met these criteria and are matured to a pre-clinical proof-of-concept phase Sanquinnovate goes on the quest to find the right partner.
Sanquinnovate works with both companies and investors that can advance the our technologies, therapeutics and devices into IND-enabling development, clinical trials and beyond. To learn more about our innovative pipeline, partnering strategy and investment possibilities, please contact our business development team at: [email protected]